Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
1.662
-0.068 (-3.93%)
At close: Aug 25, 2025, 4:00 PM
1.660
-0.002 (-0.12%)
After-hours: Aug 25, 2025, 5:20 PM EDT
Mangoceuticals Revenue
Mangoceuticals had revenue of $168.11K in the quarter ending June 30, 2025, with 3.03% growth. This brings the company's revenue in the last twelve months to $516.03K, down -40.47% year-over-year. In the year 2024, Mangoceuticals had annual revenue of $615.87K, down -15.81%.
Revenue (ttm)
$516.03K
Revenue Growth
-40.47%
P/S Ratio
15.46
Revenue / Employee
$172,010
Employees
3
Market Cap
17.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 615.87K | -115.62K | -15.81% |
| Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
| Dec 31, 2022 | 8.94K | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 3 months ago - Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu - GlobeNewsWire
- 4 months ago - ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - Newsfile Corp
- 4 months ago - CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 4 months ago - ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile Corp
- 4 months ago - Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - GlobeNewsWire
- 4 months ago - CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Accesswire
- 7 months ago - Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation - GlobeNewsWire
- 8 months ago - Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent - GlobeNewsWire